Effects of Brain-derived Neurotrophic Factor on 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in Monkeys

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Burns, R. S., Chiueh, C. C., Markey, S. P., Ebert, M. H., Jacobowitz, D. M., & Kopin, I. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4546 · Cited by 2,149

Purification of a new neurotrophic factor from mammalian brain.

Barde, Y. A., Edgar, D., & Thoenen, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01207.x · Cited by 1,822

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

Hyman, C., Hofer, M., Barde, Y., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., & Lindsay, R. M. (1991) · Nature · doi:10.1038/350230a0 · Cited by 1,503

The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor

Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V., & Parada, L. F. (1991) · Science · doi:10.1126/science.1850549 · Cited by 1,379

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,377

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,273

Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family

Hohn, A., Leibrock, J., Bailey, K., & Barde, Y.-A. (1990) · Nature · doi:10.1038/344339a0 · Cited by 1,145

Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF

Kaplan, D. R., Martı́n-Zanca, D., & Parada, L. F. (1991) · Nature · doi:10.1038/350158a0 · Cited by 1,059

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

Langston, J. W., Forno, L. S., Rebert, C. S., & Irwin, I. (1984) · Brain Research · doi:10.1016/0006-8993(84)90777-7 · Cited by 922

trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor

Squinto, S. P., Stitt, T. N., Aldrich, T. H., Davis, S. H., Blanco, S. M., Radziejewski, C. H., Glass, D. J., Masiakowski, P., Furth, M. E., Valenzuela, D. M., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90395-f · Cited by 838

The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor

Soppet, D., Escandon, E., Maragos, J., Middlemas, D. S., Raid, S. W., Blair, J., Burton, L. E., Stanton, B. R., Kaplan, D. R., Hunter, T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90396-g · Cited by 820

Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section

Sendtner, M., Holtmann, B., Kolbeck, R., Thoenen, H., & Barde, Y. (1992) · Nature · doi:10.1038/360757a0 · Cited by 706

Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain.

Ernfors, P., Ibáñez, C. F., Ebendal, T., Olson, L., & Persson, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5454 · Cited by 700

Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death

Yan, Q., Elliott, J. L., & Snider, W. D. (1992) · Nature · doi:10.1038/360753a0 · Cited by 659

The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease

Tetrud, J. W., & Langston, J. W. (1989) · Science · doi:10.1126/science.2502843 · Cited by 635

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

Turski, L., Bressler, K., Rettig, K.-J., Löschmann, P. A., & Wachtel, H. (1991) · Nature · doi:10.1038/349414a0 · Cited by 546

Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-1328k in cultured hippocampal neurons

Mattson, M. P., Rychlik, B., Chu, C., & Christakost, S. (1991) · Neuron · doi:10.1016/0896-6273(91)90120-o · Cited by 524

Brain-derived neurotrophic factor prevents neuronal death in vivo

Hofer, M., & Barde, Y. (1988) · Nature · doi:10.1038/331261a0 · Cited by 497

Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture

Mattson, M., Murrain, M., Guthrie, P., & Kater, S. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-11-03728.1989 · Cited by 480

Brain‐Derived Neurotrophic Factor Protects Dopamine Neurons Against 6‐Hydroxydopamine and N‐Methyl‐4‐Phenylpyridinium Ion Toxicity: Involvement of the Glutathione System

Spina, M. B., Squinto, S. P., Miller, J. M., Lindsay, R. M., & Hyman, C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08880.x · Cited by 460

Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death

Oppenheim, R. W., Yin, Q.-W., Prevette, D. M., & Yan, Q. (1992) · Nature · doi:10.1038/360755a0 · Cited by 447

1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra

Langston, J. W., Irwin, I., Langston, E. B., & Forno, L. S. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90293-3 · Cited by 435

Function and evolution in the NGF family and its receptors

Ebendal, T. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490320402 · Cited by 347

Blood-Brain Barrier Penetration and in Vivo Activity of an NGF Conjugate

Friden, P. M., Walus, L. R., Watson, P. M., Doctrow, S. R., Kozarich, J. W., Bäckman, C. M., Bergman, H., Hoffer, B. J., Bloom, F. E., & Granholm, A. (1993) · Science · doi:10.1126/science.8420006 · Cited by 324

Nerve growth factor affects11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (Case Report)

Olson, L., Nordberg, A. K., von Holst, H., Bäckman, L., Ebendal, T., Alafuzoff, I. I., Amberla, K., Hartvig, P., Herlitz, A., Lilja, A., et al. (1992) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257624 · Cited by 323

Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis

Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben‐Shachar, D., & Youdim, M. B. H. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08362.x · Cited by 313

Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Bankiewicz, K. S., Oldfield, E. H., Chiueh, C. C., Doppman, J. L., Jacobowitz, D. M., & Kopin, I. J. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90431-5 · Cited by 308

Keeping track of neurotrophin receptors

Bothwell, M. A. (1991) · Cell · doi:10.1016/0092-8674(91)90540-f · Cited by 292

Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain

Knüsel, B., Beck, K., Winslow, J. W., Rosenthal, A., Burton, L., Widmer, H., Nikolics, K., & Hefti, F. F. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-11-04391.1992 · Cited by 278

Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo.

Altar, C. A., Boylan, C. B., Jackson, C., Hershenson, S., Miller, J., Wiegand, S. J., Lindsay, R. M., & Hyman, C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11347 · Cited by 275

ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, AND MOTONEURONE DISEASE: ABIOTROPIC INTERACTION BETWEEN AGEING AND ENVIRONMENT?

Calne, D. B., McGeer, E. G., Eisen, A., & Spencer, P. S. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90469-1 · Cited by 255

Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐Phenylpyridinium

Vyas, I. L., Heikkila, R. E., & Nicklas, W. J. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb01768.x · Cited by 239

Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat

Chiueh, C. C., Markey, S. P., Burns, R. S., Johannessen, J. N., Pert, A., & Kopin, I. J. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90221-8 · Cited by 224

Regulation of microtubule composition and stability during nerve growth factor-promoted neurite outgrowth.

Black, M. M., Aletta, J. M., & Greene, L. (1986) · The Journal of Cell Biology · doi:10.1083/jcb.103.2.545 · Cited by 154

MK‐801 Prevents 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐Induced Parkinsonism in Primates

Zuddas, A., Oberto, G., Vaglini, F., Fascetti, F., Fornai, F., & Corsini, G. U. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09429.x · Cited by 154

V. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Castagnoli, N., Chiba, K., & Trevor, A. J. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90063-3 · Cited by 153

Genetically modified cells: applications for intracerebral grafting

Gage, F. H., Kawaja, M. D., & Fisher, L. J. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90156-o · Cited by 147

COGNITIVE AND MOTOR DEFICITS IN THE ACQUISITION OF AN OBJECT RETRIEVAL/DETOUR TASK IN MPTP-TREATED MONKEYS

Taylor, J. R., Elsworth, J. D., Roth, R. H., Sladek, J. R., & Redmond, D. E. (1990) · Brain · doi:10.1093/brain/113.3.617 · Cited by 140

Oral levodopa dose‐response study in MPTP‐induced hemiparkinsonian monkeys: Assessment with a new rating scale for monkey parkinsonism

Kurlan, R., Kim, M. H., & Gash, D. M. (1991) · Movement Disorders · doi:10.1002/mds.870060205 · Cited by 117

The Role of Brain-derived Neurotrophic Factor in Transient Forebrain Ischemia in the Rat Brain

Tsukahara, T., Yonekawa, Y., Tanaka, K., Ohara, O., Watanabe, S., Kimura, T., Nishijima, T., & Taniguchi, T. (1994) · Neurosurgery · doi:10.1227/00006123-199402000-00016 · Cited by 114

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF

Elsworth, J. D., Deutch, A. Y., Redmond, D. E., Sladek, J. R., & Roth, R. H. (1987) · Brain Research · doi:10.1016/0006-8993(87)90211-3 · Cited by 102

Evidence that the blockade of mitochondrial respiration by the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) involves binding at the same site as the respiratory inhibitor, rotenone

Krueger, M. J., Singer, T. P., Casida, J. E., & Ramsay, R. R. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91442-u · Cited by 85

Mechanisms of cholecystokinin-induced protection of cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity

Tamura, Y., Sato, Y., Akaike, A., & Shiomi, H. (1992) · Brain Research · doi:10.1016/0006-8993(92)91691-7 · Cited by 84

Delivery of Trophic Factors to the Primate Brain

Kordower, J. H., Mufson, E. J., Granholm, A., Hoffer, B. J., & Friden, P. M. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1169 · Cited by 84

Chapter 62 Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Fine, A., Hunt, S. P., Oertel, W. H., Nomoto, M., Chong, P. N., Bond, A., Waters, C. M., Temlett, J. A., Annett, L. E., Dunnett, S. B., et al. (1988) · Progress in brain research · doi:10.1016/s0079-6123(08)60321-0 · Cited by 81

Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls

Taylor, J. R., Elsworth, J. D., Roth, R. H., Sladek, J. R., Collier, T. J., & Redmond, D. E. (1991) · Experimental Brain Research · doi:10.1007/bf00229411 · Cited by 75

Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: Relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake

Mitchell, I., Cross, A. J., Sambrook, M. A., & Crossman, A. R. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90013-3 · Cited by 72

Cell culture of cryopreserved human fetal cerebral cortical and hippocampal neurons: neuronal development and responses to trophic factors

Mattson, M. P., & Rychlik, B. (1990) · Brain Research · doi:10.1016/0006-8993(90)91462-p · Cited by 72

Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum

Elsworth, J. D., Deutch, A. Y., Redmond, D. E., Sladek, J. R., & Roth, R. H. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90359-6 · Cited by 67

Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons

Shimohama, S., Tamura, Y., Akaike, A., Tsukahara, T., Ohara, O., Watanabe, S., & Kimura, J. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90856-g · Cited by 62

The time course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐tetrahydropyridine to monkeys

Kurlan, R., Kim, M. H., & Gash, D. M. (1991) · Annals of Neurology · doi:10.1002/ana.410290618 · Cited by 56

Behavioral Effects of MPTP Administration in the Vervet Monkey

Taylor, J. R., Elsworth, J. D., Roth, R. H., Sladek, J. R., & Redmond, D. E. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1447-7_6 · Cited by 55

Alterations of a 200 kDa Neurofilament in the Rat Hippocampus after Forebrain Ischemia

Kaku, Y., Yonekawa, Y., Tsukahara, T., Ogata, N., Kimura, T., & Taniguchi, T. (1993) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1993.54 · Cited by 52

MPTP-induced parkinsonism in monkeys: Mechanism of action, selectivity and pathophysiology

Schultz, W. (1988) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(88)90055-9 · Cited by 42

Production of human thyroid-stimulating hormone in Chinese hamster ovary cells

Watanabe, S., Hayashizaki, Y., Endo, Y., Hirono, M., Takimoto, N., Tamaki, M., Teraoka, H., Miyal, K., & Matsubara, K. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90528-6 · Cited by 33

On Guiding Principles for Animal Experiments Using Nonhuman Primates

Honjo, S. (1986) · Primate Research · doi:10.2354/psj.2.109 · Cited by 30

Grafts and Growth Factors in CNS

Olson, L. (1990) · Stereotactic and Functional Neurosurgery · doi:10.1159/000100220 · Cited by 21

Effect of nerve growth factor on delayed neuronal death and microtubule-associated protein 2 after transient cerebral ischaemia in the rat

Tanaka, K., Tsukahara, T., Kaku, Y., Hashimoto, N., Yonekawa, Y., Ogata, N., Kimura, T., & Taniguchi, T. (1994) · Journal of Clinical Neuroscience · doi:10.1016/0967-5868(94)90088-4 · Cited by 9

Brain-derived neurotrophic factor in neurodegenerative diseases

Zuccato, C., & Cattaneo, E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.54 · Cited by 947

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease

Murer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874

Potential therapeutic uses of BDNF in neurological and psychiatric disorders

Nagahara, A. H., & Tuszynski, M. H. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3366 · Cited by 867

The role of neuronal growth factors in neurodegenerative disorders of the human brain

Connor, B. J., & Dragunow, M. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00004-6 · Cited by 538

Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra

Howells, D. W., Porritt, M. J., Wong, J. Y. F., Batchelor, P. E., Kalnins, R., Hughes, A. J., & Donnan, G. A. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7483 · Cited by 513

Histological Effects of Intraputaminal Infusion of Glial Cell Line-Derived Neurotrophic Factor in Parkinson Disease Model Macaque Monkeys

Oiwa, Y., NAKAI, K., & Itakura, T. (2006) · Neurologia medico-chirurgica · doi:10.2176/nmc.46.267 · Cited by 21

Effects of Brain derived neurotrophic factor (BDNF) on substantial nigra dopaminergic neurons in Parkinson dis- ease rats

Lu, Y. (2000)

Intracerebroventricularly-administered 1-methyl-4-phenylpyridinium ion and brain-derived neurotrophic factor affect catecholaminergic nerve terminals and neurogenesis in the hippocampus, striatum and substantia nigra

Behnisch, T., Chen, J.-F., Wang, M., & Zhuang, Y. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.230300 · Cited by 8

Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat

Frim, D. M., Uhler, T. A., Galpern, W. R., Beal, M. F., Breakefield, X. O., & Isacson, O. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.5104 · Cited by 269

Functional recovery in parkinsonian monkeys treated with GDNF

Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., et al. (1996) · Nature · doi:10.1038/380252a0 · Cited by 955